Workflow
能特科技跌2.06%,成交额1.49亿元,主力资金净流出2591.77万元

Company Overview - Nengte Technology Co., Ltd. is located in Jingzhou, Hubei Province, and was established on September 28, 2002. The company was listed on December 29, 2006. Its main business includes the research, production, and sales of pharmaceutical intermediates, investment in the research, production, and sales of Vitamin E, e-commerce for plastic trade, rental of investment properties, and gold mining [1]. Financial Performance - As of June 30, 2025, Nengte Technology reported a revenue of 5.229 billion yuan, a year-on-year decrease of 16.09%. However, the net profit attributable to shareholders increased significantly by 496.36% to 339 million yuan [2]. - The company has cumulatively distributed 152 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3]. Stock Performance - On September 16, Nengte Technology's stock price decreased by 2.06%, trading at 4.27 yuan per share, with a total market capitalization of 10.571 billion yuan. The stock has increased by 62.98% year-to-date, but has seen a decline of 3.83% over the last five trading days [1]. - The stock's trading volume on September 16 was 149 million yuan, with a turnover rate of 1.58%. The net outflow of main funds was 25.917 million yuan, with significant selling pressure observed [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Nengte Technology was 42,100, a slight decrease of 0.06% from the previous period. The average number of circulating shares per person increased by 0.06% to 55,391 shares [2]. - Notably, Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3]. Business Segmentation - The company's revenue composition is primarily from plastic raw materials (91.39%), followed by pharmaceutical intermediates (8.39%), and rental income from properties (0.22%) [1]. - Nengte Technology is classified under the pharmaceutical and biological industry, specifically in chemical pharmaceuticals and raw materials [1].